Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Alastair Greystoke, MBChB, MSc, PhD, MRCP, Northern Institute for Cancer Research, Newcastle University, Newcastle, UK, shares his highlights from the 19th British Thoracic Oncology Group (BTOG) Annual Conference 2021, commenting on the impacts of the COVID-19 pandemic.
Disclosures
Alastair Greystoke, MBChB, MSc, PhD, MRCP, has received consultancy and speaker fees from AstraZeneca, Amgen, Boehringer-Ingelheim, Bristol-Myers Squibb, Janssen/ J and J, Foundation Medicine, MSD, Novartis, Pfizer, Lilly, Takeda and Roche; and has received research funding from AstraZeneca.
We use necessary cookies to make this site work. Analytics, preference, and marketing cookies are used only if you choose to allow them. You can change your choice at any time. For more information view our Cookie Policy.